FGF14 and multiple system atrophy: Our study did not find significant differences in α-synuclein pathology on neuropathological examination among MSA patients with or without FGF14 GAA•TTC expansions, suggesting that these genetic mutations might contribute to the MSA phenotype through mechanisms independent of α-synuclein aggregation.